ExPLoRNA Therapeutics receives funding to advance its novel mRNA technology
14-Dec-2022 -
ExPLoRNA Therapeutics, a Polish biotech company revolutionizing mRNA vaccines and therapeutics with unprecedented translational efficiency, received funding from the Bill & Melinda Gates Foundation to further develop its unique mRNA technology. ExPLoRNA specializes in novel cap analogs, the ...
funding
mRNA therapies
mRNA vaccines